Rua Bioscience Confirms First International Order
19/10/2022
http://nzx-prod-s7fsd7f98s.s3-website-ap-southeast-2.amazonaws.com/attachments/RUA/400796/381494.pdf
Rua Bioscience Limited (NZX: RUA) formally announced today that it has received its first order via its German distributer Nimbus Health, marking a significant commercial milestone for the export-focused company.
Managing Director, Anna Stove, says “Receiving this order for dried flower from Nimbus signifies just how close we are to cementing export revenues and providing German patients with a sustainable supply of Rua medicines”.
The order is for Rua’s high THC flower, which has been developed through an extensive R&D programme by Cann Group, Rua’s Australian manufacturing, supply and technical services partner. In Germany, medicinal dried-cannabis flower is prescribed mainly for pain patients (70%), and cannabis flowers with a THC content of greater than 20% make up 77% of cannabis flower prescriptions.
“At its launch, we believe Rua’s flower will be one of the highest THC dried flower medicines on the market, which will give Rua a significant competitive advantage,” she says.
- Forums
- ASX - By Stock
- Interesting cannabis articles and worldwide updates.
Rua Bioscience Confirms First International Order 19/10/2022...
Featured News
Add CAN (ASX) to my watchlist
(20min delay)
|
|||||
Last
6.0¢ |
Change
0.015(33.3%) |
Mkt cap ! $28.11M |
Open | High | Low | Value | Volume |
4.8¢ | 6.3¢ | 4.8¢ | $200.7K | 3.690M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 6563 | 6.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
6.3¢ | 22466 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 6563 | 0.060 |
1 | 12500 | 0.058 |
1 | 179634 | 0.057 |
1 | 40701 | 0.056 |
2 | 169060 | 0.055 |
Price($) | Vol. | No. |
---|---|---|
0.063 | 22466 | 1 |
0.064 | 167218 | 1 |
0.065 | 831157 | 3 |
0.069 | 7856 | 1 |
0.074 | 3000 | 1 |
Last trade - 15.57pm 27/09/2024 (20 minute delay) ? |
Featured News
CAN (ASX) Chart |